Current diagnostic tools for Sjögren's syndrome

International Journal of Clinical Rheumatology

Volumn 8, Issue 2, 2013, Pages 281-290

  Duquenne, Carole ^a   Cornec, Divi ^a,b   Pers, Jacques Olivier ^b   Jousse Joulin, Sandrine ^a,b   Guellec, Dewi ^a   Devauchelle Pensec, Valérie ^a,b   Saraux, Alain ^a,b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Universite de Brest   (France)

Author keywords

activity; classification criteria; diagnosis; disease; primary Sj gren's syndrome; prognosis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ANTINUCLEAR ANTIBODY; ANTIPARKINSON AGENT; ANTIRETROVIRUS AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IMIPRAMINE; ISOTRETINOIN; LA ANTIBODY; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; RO ANTIBODY; ROSE BENGAL; SEROTONIN UPTAKE INHIBITOR;

B LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRY EYE; ECHOGRAPHY; FATIGUE; HUMAN; KERATOCONJUNCTIVITIS SICCA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAROTID ENLARGEMENT; PAROTID GLAND; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND BIOPSY; SALIVARY GLAND SCINTISCANNING; SALIVATION; SCHIRMER TEST; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIALOGRAPHY; SJOEGREN SYNDROME; T LYMPHOCYTE; XEROSTOMIA;

EID: 84875697804     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.13.4     Document Type: Review

References (43)

1. Binard A, Devauchelle-Pensec V, Frautrel B, Jousse S, Youinou P, Saraux A. Epidemiology of Sjögren's syndrome: where are we now? Clin. Exp. Rheumatol. 25, 1-4 (2007)..
2. Maldini C, Seror R, Fain O et al. Population-based prevalence of primary Sjögren's syndrome: a 5-source capture-recapture estimate. Arthritis Rheum. 60, 487 (2009)..
3. Pijpe J, Kalk WWI, Bootsma H, Spijkervet FKL, Kallenberg CGM, Vissink A. Progression of salivary gland dysfunction in patients with Sjögren's syndrome. Ann. Rheum. Dis. 66, 107-112 (2007)..
4. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J. Clin. Pathol. 21, 656-660 (1968)..
5. Al-Hashimi I, Wright JM, Cooley CA, Nunn ME. Reproducibility of biopsy grade in Sjögren's syndrome. J. Oral Pathol. Med. 30, 408-412 (2001)..
6. Takeda Y, Komori A. Focal lymphocytic infiltration in the human labial salivary glands: a postmortem study. J. Oral Pathol. 15, 83-86 (1986)..
7. Yarom N, Dayan D, Buchner A, Vered M. Immunoprofile of focal lymphocytic infiltration in minor salivary glands of healthy individuals. Oral Dis. 13, 274-278 (2007)..
8. Guellec D, Cornec D, Jousse-Joulin S et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. Autoimmun. Rev. 12(3), 416-420 (2012)..
9. Pollard RP, Pijpe J, Bootsma H et al. Treatment of mucosa-Associated lymphoid tissue lymphoma in Sjögren's syndrome: a retrospective clinical study. J. Rheumatol. 38, 2198-2208 (2011)..
10. Cox D, Shiboski CH, Schiødt M et al. Sjögren's International Collaborative Clinical Alliance Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum. 63, 2021-2030 (2011)..
11. Theander E, Vasaitis L, Baecklund E et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann. Rheum. Dis. 70(8), 1363-1368 (2011)..
12. van Bijsterveld OP. Standardization of the lysozyme test for a commercially available medium. Its use for the diagnosis of the sicca syndrome. Arch. Ophthalmol. 91, 432-434 (1974)..
13. Whitcher JP, Shiboski CH, Shiboski SC et al. Sjögren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am. J. Ophthalmol. 149, 405-415 (2010)..
14. Cornec D, Jousse-Joulin S, Pers JO et al. Contribution of salivary gland ultrasonography to thr diagnosis of Sjögren syndrome: towards new diasgnostic criteria? Arthritis Rheum. 65, 216-225 (2013)..
15. Takagi Y, Kimura Y, Nakamura H, Sasaki M, Eguchi K, Nakamura T. Salivary gland ultrasonography: can it be an alternative to sialography as an imaging modality for Sjogren's syndrome? Ann. Rheum. Dis. 69, 1321-1324 (2010)..
16. Carotti M, Salaffi F, Manganelli P, Argalia G. Ultrasonography and colour doppler sonography of salivary glands in primary Sjögren's syndrome. Clin. Rheumatol. 20, 213-219 (2001)..
17. Makula E, Pokorny G, Rajtár M, Kiss I, Kovács A, Kovács L. Parotid gland ultrasonography as a diagnostic tool in primary Sjögren's syndrome. Br. J. Rheumatol. 35, 972-977 (1996).
18. kula E, Pokorny G, Kiss M et al. The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjögren's syndrome. Rheumatology (Oxford) 39, 97-104 (2000)..
19. Milic VD, Petrovic RR, Boricic IV et al. Major salivary gland sonography in Sjögren's syndrome: diagnostic value of a novel ultrasonography score (0-12) for parenchymal inhomogeneity. Scand. J. Rheumatol. 39, 160-166 (2010)..
20. De Vita S, Lorenzon G, Rossi G, Sabella M, Fossaluzza V. Salivary gland echography in primary and secondary Sjögren's syndrome. Clin. Exp. Rheumatol. 10, 351-356 (1992)..
21. Gritzmann N, Rettenbacher T, Hollerweger A, Macheiner P, Hübner E. Sonography of the salivary glands. Eur. Radiol. 13, 964-975 (2003)..
22. Chikui T, Yonetsu K, Izumi M, Eguchi K, Nakamura T. Abnormal blood flow to the submandibular glands of patients with Sjögren's syndrome: Doppler waveform analysis. J. Rheumatol. 27, 1222-1228 (2000)..
23. Jousse-Joulin S, Devauchelle-Pensec V, Morvan J et al. Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: quantitative and Doppler waveform analysis. Biologics 1, 311-319 (2007)..
24. Binard A, Le Pottier L, Devauchelle-Pensec V, Saraux A, Youinou P, Pers JO. Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann. Rheum. Dis. 68, 1447-1452 (2009)..
25. Shearn MA. Sjogren's syndrome. Semin. Arthritis Rheum. 2, 165-190 (1972)..
26. Daniels TE, Benn DK. Is sialography effective in diagnosing the salivary component of Sjögren's syndrome? Adv. Dent. Res. 10, 25-28 (1996)..
27. Cummings NA, Schall GL, Asofski R. Sjogren's syndrome -newer aspects of research, diagnosis, and therapy. Ann. Intern. Med. 75, 937-950 (1971)..
28. Markusse HM, Pillay M, Breedveld FC. The diagnostic value of salivary gland scintigraphy in patients suspected of primary Sjogren's syndrome. Br. J. Rheumatol. 32, 231-235 (1993)..
29. Ramos-Casals M, Brito-Zerón P, Perez-DE-Lis M et al. Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren's syndrome. J. Rheumatol. 37, 585-590 (2010)..
30. Tonami H, Higashi K, Matoba M, Yokota H, Yamamoto I, Sugai S. A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome. J. Comput. Assist. Tomogr. 25, 262-268 (2001)..
31. Ohbayashi N, Yamada I, Yoshino N, Sasaki T. Sjogren syndrome: comparison of assessments with MR sialography and conventional sialography. Radiology 209, 683-688 (1998)..
32. El Miedany YM, Ahmed I, Mourad HG et al. Quantitative ultrasonography and magnetic resonance imaging of the parotid gland: can they replace the histopathologic studies in patients with Sjogren's syndrome? Joint Bone Spine 71, 29-38 (2004)..
33. Kalk WW, Vissink A, Spijkervet FK, Bootsma H, Kallenberg CG, Nieuw Amerongen AV. Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome. Ann. Rheum. Dis. 60, 1110-1116 (2001)..
34. Hu S, Gao K, Pollard R et al. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res. (Hoboken) 62, 1633-1638 (2010)..
35. Hu S, Vissink A, Arellano M et al. Identification of antoantibody biomarkers for primary Sjögren's syndrome using protein microarrays. Proteomics 11, 1499-1507 (2011)..
36. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554-558 (2002)..
37. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort. Sjögren's International Collaborative Clinical Alliance (SICCA) Research Groups. Arthritis Care Res. (Hoboken) 64, 475-487 (2012)..
38. Vitali C, Bootsma H, Bowman SJ et al. Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann. Rheum. Dis. 72(4), 476-478 (2013)..
39. Seror R, Ravaud P, Mariette X et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann. Rheum. Dis. 70, 968-972 (2011)..
40. Vitali C, Palombi G, Baldini C et al. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 56, 2223-2231 (2007)..
41. Seror R, Ravaud P, Bowman SJ et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann. Rheum. Dis. 69, 1103-1109 (2010)..
42. Seror R, Mariette X, Bowman S et al. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care Res. (Hoboken). 62, 551-558 (2010)..
43. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88, 284-293 (2009)..